Fingerprint
Dive into the research topics of 'An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)
Mark H. Gotfried, Carlos E. Girod, Danielle Antin-Ozerkis, Tracy Burgess, Indiana Strombom, John L. Stauffer, Klaus Uwe Kirchgaessler, Maria L. Padilla
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations